By KIM BELLARD Chances are someone in your family is a gamer. Maybe you are a gamer yourself. After all, somewhere between two-thirds and three-fourths of Americans play video games, and if you just looked at young men, it’d be closer to 100%. Grumpy older people don’t get it, complaining that gaming is just a…
HeartFlow, which makes AI tools to analyze cardiac images, sued its rival Cleerly, alleging infringement on six patents. Cleerly is pushing back. The post Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft appeared first on MedCity News.
Vida Health is partnering with ŌURA to use data from the Oura Ring to provide more continuous, personalized cardiometabolic care and improve patient outcomes. The post Vida Health Teams Up with ŌURA to Provide More Personalized Metabolic Care appeared first on MedCity News.
Travere Therapeutics’ Filspari is now the first FDA-approved drug for focal segmental glomerulosclerosis (FSGS), a rare kidney disease. Analysts project the pill will become a blockbuster seller. The post Bouncing Back From Trial Failure, Travere Wins First FDA Approval in Rare Kidney Disease appeared first on MedCity News.
That is the title of my latest Perspectives from the Healthcare Economist article published in The Evidence Base this week. Here is the teaser: In this guest column, healthcare economist Jason Shafrin (FTI Consulting and Mann School of Pharmacy, University of Southern California) explores a widening divide over how health systems define value, and what that means…
[Sponsored] 74% of healthcare AI is stuck in pilots. The reason isn’t the AI, it’s the data architecture underneath it. Read more to find the solution. The post 5 of the Top 10 U.S. Health Systems Are Moving to This New Health IT Category. Here’s Why. appeared first on MedCity News.
CMO Jeffrey Giullian, M.D., M.B.A., describes how DaVita is using machine learning to improve outcomes for those receiving dialysis at home
To address the clinical burden and enhance R&D, companies are turning to virtual solutions. This involves synthetic data, digital twin models, and AI to speed analysis. The post Why Synthetic Data is the Antidote to Clinical Trials appeared first on MedCity News.
Mientras las autoridades migratorias llevan a cabo lo que el presidente Donald Trump ha prometido que será la mayor operación de deportación masiva en la historia de Estados Unidos, varios estados están aprobando leyes para evitar que los niños de padres detenidos, sin otros familiares o amigos, entren al sistema de cuidado temporal. El gobierno…
The question is where will healthcare see the greatest value? Here are five use cases that define the greatest ROI for leveraging agentic AI for clinical supply chain operations. The post Clinical Supply Chain Hits Its AI Turning Point appeared first on MedCity News.